Total Payments
$15,082
2024 Payments
$1,447
Companies
45
Transactions
843
Medicare Patients
17,296
Medicare Billing
$2.7M
Payment Breakdown by Category
Food & Beverage$15,075 (100.0%)
Education$6.95 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,075 | 841 | 100.0% |
| Education | $6.95 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $3,935 | 237 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,491 | 135 | $0 (2024) |
| Boston Scientific Corporation | $1,199 | 24 | $0 (2024) |
| Amgen Inc. | $1,069 | 71 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $849.53 | 62 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $791.80 | 58 | $0 (2024) |
| PFIZER INC. | $607.36 | 30 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $516.57 | 21 | $0 (2024) |
| Novo Nordisk Inc | $497.33 | 27 | $0 (2024) |
| Medtronic, Inc. | $455.17 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,447 | 77 | Amgen Inc. ($236.34) |
| 2023 | $1,704 | 87 | Abbott Laboratories ($341.63) |
| 2022 | $1,782 | 113 | Novartis Pharmaceuticals Corporation ($260.20) |
| 2021 | $2,581 | 137 | Abbott Laboratories ($1,318) |
| 2020 | $1,018 | 50 | Abbott Laboratories ($405.70) |
| 2019 | $2,575 | 138 | Abbott Laboratories ($724.78) |
| 2018 | $1,735 | 114 | Abbott Laboratories ($658.56) |
| 2017 | $2,240 | 127 | Novartis Pharmaceuticals Corporation ($398.09) |
All Payment Transactions
843 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Obesity | ||||||
| 12/09/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $19.00 | General |
| 12/03/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: Obesity | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: Obesity | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $12.92 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Genetic Disease | ||||||
| 11/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.10 | General |
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Obesity | ||||||
| 10/15/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $17.32 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: Obesity | ||||||
| 10/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiology | ||||||
| 10/07/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/27/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $57.16 | General |
| Category: LUX-Dx_CRM | ||||||
| 09/26/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $18.19 | General |
| 09/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.45 | General |
| Category: Cardiovascular | ||||||
| 09/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.06 | General |
| Category: Cardiovascular | ||||||
| 09/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.01 | General |
| Category: Cardiovascular | ||||||
| 09/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $3.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/26/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $5.83 | General |
| Category: Cardiovascular | ||||||
| 08/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $5.71 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 4,761 | 8,280 | $1.1M | $704,675 |
| 2022 | 37 | 4,562 | 8,328 | $1.0M | $618,035 |
| 2021 | 38 | 4,150 | 7,969 | $1.1M | $741,792 |
| 2020 | 39 | 3,823 | 7,068 | $1.1M | $636,559 |
Total Patients
17,296
Total Services
31,645
Medicare Billing
$2.7M
Procedure Codes
164
All Medicare Procedures & Services
164 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 481 | 861 | $170,478 | $122,435 | 71.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 610 | 1,113 | $166,950 | $110,458 | 66.2% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 106 | 107 | $112,674 | $80,379 | 71.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 312 | 955 | $95,500 | $63,596 | 66.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 281 | 636 | $81,309 | $63,343 | 77.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 267 | 268 | $100,500 | $43,553 | 43.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 199 | 206 | $46,350 | $29,989 | 64.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 138 | 138 | $35,880 | $22,468 | 62.6% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2023 | 14 | 17 | $29,630 | $19,973 | 67.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 737 | 1,686 | $59,010 | $19,706 | 33.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 44 | 44 | $26,400 | $16,876 | 63.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 46 | 47 | $13,756 | $10,116 | 73.5% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 19 | 20 | $12,956 | $9,716 | 75.0% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 49 | 54 | $12,420 | $9,109 | 73.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 43 | 43 | $15,050 | $8,116 | 53.9% |
| 93924 | Ultrasound of leg arteries at rest and after exercise | Office | 2023 | 51 | 52 | $10,087 | $7,077 | 70.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 41 | 41 | $9,134 | $7,006 | 76.7% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 86 | 86 | $8,600 | $6,336 | 73.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 99 | 102 | $15,525 | $5,813 | 37.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 31 | 121 | $7,363 | $5,606 | 76.1% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 44 | 260 | $7,787 | $5,105 | 65.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 80 | 81 | $9,315 | $4,443 | 47.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 334 | 491 | $14,730 | $3,274 | 22.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 23 | 26 | $5,148 | $3,139 | 61.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 44 | 44 | $4,063 | $3,069 | 75.5% |
About Dr. Edward Choi, M.D
Dr. Edward Choi, M.D is a Cardiovascular Disease healthcare provider based in Neptune, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255362604.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Choi, M.D has received a total of $15,082 in payments from pharmaceutical and medical device companies, with $1,447 received in 2024. These payments were reported across 843 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($15,075).
As a Medicare-enrolled provider, Choi has provided services to 17,296 Medicare beneficiaries, totaling 31,645 services with total Medicare billing of $2.7M. Data is available for 4 years (2020–2023), covering 164 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Neptune, NJ
- Active Since 07/05/2006
- Last Updated 09/25/2012
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1255362604
Products in Payments
- ENTRESTO (Drug) $1,155
- Xience Sierra Coronary Stent System (Device) $1,138
- XARELTO (Drug) $849.53
- ELIQUIS (Drug) $802.54
- Repatha (Biological) $662.90
- Xience Alpine cornary stent system (Device) $573.40
- Xience Sierra Coronary Stent (Device) $549.18
- Optis Coronary Imaging System (Device) $468.88
- Impella (Device) $448.27
- JARDIANCE (Drug) $421.98
- VYNDAQEL (Drug) $405.45
- Corlanor (Drug) $368.59
- BRILINTA (Drug) $355.63
- LEQVIO (Drug) $336.26
- Vascepa (Drug) $333.23
- WATCHMAN (Device) $299.79
- Ozempic (Drug) $251.05
- Endurant (Device) $239.87
- Barostim Neo System (Device) $233.09
- PRALUENT (Drug) $222.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Neptune
Dr. Renato Apolito, M.d, M.D
Cardiovascular Disease — Payments: $30,948
Cardiovascular Disease $30,948
Dr. Ravi Diwan, Md, MD
Cardiovascular Disease — Payments: $26,864
Cardiovascular Disease $26,864
Laith Zamel, M.d, M.D
Cardiovascular Disease — Payments: $23,335
Cardiovascular Disease $23,335
James Orlando, M.d, M.D
Cardiovascular Disease — Payments: $23,239
Cardiovascular Disease $23,239
Kenneth Harris, Md, MD
Cardiovascular Disease — Payments: $19,358
Cardiovascular Disease $19,358
Maurice Weiss, M.d, M.D
Cardiovascular Disease — Payments: $15,297
Cardiovascular Disease $15,297